Federal Officials Want Easier Testosterone Prescriptions. The Harder Question Is Wisdom

The push to ease prescribing is not only a regulatory step. It puts a long-running process in public view: officials move to widen access, while the medical debate over benefits and risks continues. That sequence matters. The hardest issue is not whether testosterone can be obtained, but how it should be used.

The debate has lasted because the hormone touches real human concerns—sex drive, mood, and other health factors—and because access can feel like an answer before the questions are finished. Ecclesiastes draws a useful line. Money and access can open many doors, but wisdom is what saves life. The verse does not rule on whether this policy change is medically sound, promise health, or treat testosterone therapy as either a cure or a threat. It warns against a simpler error: assuming that because something is available, it is good for us.

That distinction reaches beyond medicine. We often ask, “Can I get this?” when wisdom asks, “What is this protecting me from?” Responsible care may include treatment, restraint, or careful evaluation. When medicine, money, and personal desire meet, the safer path is to let wisdom, not availability, set the pace.